Flagship Harbor Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.72M | Sell |
26,269
-652
| -2% | -$58.2K | 0.1% | 179 |
|
|
2026
Q1 | $1.93M | Sell |
26,921
-395
| -1% | -$30.4K | 0.09% | 204 |
|
|
2025
Q4 | $2.17M | Sell |
27,316
-3,245
| -11% | -$256K | 0.1% | 182 |
|
|
2025
Q3 | $2.3M | Buy |
30,561
+240
| +0.8% | +$16.4K | 0.1% | 182 |
|
|
2025
Q2 | $2.09M | Sell |
30,321
-1,072
| -3% | -$70.3K | 0.1% | 195 |
|
|
2025
Q1 | $2.13M | Sell |
31,393
-63
| -0.2% | -$3.77K | 0.11% | 167 |
|
|
2024
Q4 | $1.41M | Buy |
31,456
+2,603
| +9% | +$146K | 0.07% | 226 |
|
|
2024
Q3 | $1.81M | Sell |
28,853
-4,534
| -14% | -$265K | 0.1% | 194 |
|
|
2024
Q2 | $1.97M | Buy |
33,387
+603
| +2% | +$37.7K | 0.12% | 170 |
|
|
2024
Q1 | $2.61M | Sell |
32,784
-2,775
| -8% | -$212K | 0.17% | 131 |
|
|
2023
Q4 | $2.81M | Buy |
35,559
+506
| +1% | +$36K | 0.2% | 108 |
|
|
2023
Q3 | $2.45M | Sell |
35,053
-1,794
| -5% | -$127K | 0.2% | 108 |
|
|
2023
Q2 | $2.55M | Buy |
36,847
+1,255
| +4% | +$89.3K | 0.21% | 109 |
|
|
2023
Q1 | $2.64M | Buy |
35,592
+1,967
| +6% | +$165K | 0.25% | 102 |
|
|
2022
Q4 | $3.13M | Sell |
33,625
-230
| -0.7% | -$22.2K | 0.32% | 84 |
|
|
2022
Q3 | $3.23M | Buy |
33,855
+852
| +3% | +$84.3K | 0.37% | 64 |
|
|
2022
Q2 | $3.06M | Buy |
33,003
+1,202
| +4% | +$117K | 0.34% | 72 |
|
|
2022
Q1 | $3.22M | Buy |
31,801
+2,135
| +7% | +$224K | 0.31% | 75 |
|
|
2021
Q4 | $3.06M | Sell |
29,666
-1,158
| -4% | -$107K | 0.29% | 77 |
|
|
2021
Q3 | $2.57M | Hold |
30,824
| – | – | 0.28% | 85 |
|
|
2021
Q2 | $2.57M | Buy |
30,824
+2,539
| +9% | +$208K | 0.28% | 85 |
|
|
2021
Q1 | $2.13M | Buy |
28,285
+1,065
| +4% | +$77.6K | 0.24% | 97 |
|
|
2020
Q4 | $1.86M | Buy |
27,220
+262
| +1% | +$17K | 0.23% | 99 |
|
|
2020
Q3 | $1.57M | Buy |
26,958
+89
| +0.3% | +$5.54K | 0.21% | 101 |
|
|
2020
Q2 | $1.75M | Sell |
26,869
-64
| -0.2% | -$4.03K | 0.26% | 82 |
|
|
2020
Q1 | $1.6M | Buy |
26,933
+2,932
| +12% | +$196K | 0.32% | 67 |
|
|
2019
Q4 | $1.78M | Sell |
24,001
-5,114
| -18% | -$359K | 0.31% | 70 |
|
|
2019
Q3 | $1.84M | Buy |
29,115
+609
| +2% | +$36.1K | 0.36% | 62 |
|
|
2019
Q2 | $1.55M | Sell |
28,506
-281
| -1% | -$15.1K | 0.32% | 72 |
|
|
2019
Q1 | $1.55M | Buy |
28,787
+10,444
| +57% | +$645K | 0.32% | 76 |
|
|
2018
Q4 | $1.2M | Buy |
18,343
+2,457
| +15% | +$183K | 0.29% | 82 |
|
|
2018
Q3 | $1.26M | Sell |
15,886
-3,026
| -16% | -$216K | 0.23% | 107 |
|
|
2018
Q2 | $1.22M | Buy |
18,912
+5,652
| +43% | +$372K | 0.24% | 100 |
|
|
2018
Q1 | $801K | Buy |
13,260
+445
| +3% | +$31.9K | 0.24% | 113 |
|
|
2017
Q4 | $1M | Sell |
12,815
-1,725
| -12% | -$125K | 0.29% | 94 |
|
|
2017
Q3 | $1.07M | Sell |
14,540
-555
| -4% | -$43.9K | 0.35% | 80 |
|
|
2017
Q2 | $1.18M | Buy |
15,095
+847
| +6% | +$66.9K | 0.41% | 72 |
|
|
2017
Q1 | $1.1M | Buy |
14,248
+584
| +4% | +$46.6K | 0.42% | 67 |
|
|
2016
Q4 | $1.1M | Buy |
+13,664
| New | +$1.11M | 0.48% | 60 |
|
Other funds holding CVS
Flagship Harbor Advisors's CVS Position: Q2 2026 in Review
Flagship Harbor Advisors reduced its CVS Health (CVS) stake by 2.4% in Q2 2026, selling an estimated $58.2K and leaving 26,269 shares worth $2.72M. The position accounts for 0.1% of the portfolio, ranked #179.
Flagship Harbor Advisors first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.23M in Q3 2022. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Flagship Harbor Advisors held 26,269 shares of CVS Health worth $2.72M as of Q2 2026.
- Flagship Harbor Advisors sold 652 CVS Health shares in Q2 2026, an estimated $58.2K.
- CVS Health made up 0.1% of Flagship Harbor Advisors's portfolio in Q2 2026, its #179 holding.
- Flagship Harbor Advisors first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
- Flagship Harbor Advisors's CVS Health position peaked at $3.23M in Q3 2022.
- 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.